Scotland · NHS Scotland MSAN
Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/5mg tablets
MSAN(2023)24 · Level 2 · issued 19 Sep 2023
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/5mg tablets are out of stock | Out of stock | — |
| 1mg but a different progesterone component remain available and will be able to support | Available | — |
| 3. Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/2.5mg tablets remain available | Available | — |
| but cannot support uplift in demand. | Available — cannot support uplift | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2023:24
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
62919f8582f201171e76444a544fd601a7d6bf6de4d95de835638b027dbf840esha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2023-24.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.